The April issue contains lots of excellent clinically-orientated papers and this month, Associate Editor Dr Nicolai Bang Foss has chosen three that caught his eye.
The first is a comparison of a new intravenous agent remimazolam vs. propofol for TIVA and we talk about depth of anaesthesia, hypotension and everything inbeteeen. The second is a new PQIP study modelling postoperative complications and their prediction. Finally, we talk about a standalone editorial on neuromuscular blockade and the gap between what we known and what we do.